TD Reiterates “C$8.50” Price Target for WELL Health Technologies (TSE:WELL)

TD set a C$8.50 price objective on WELL Health Technologies (TSE:WELL) in a research note released on Monday morning,BayStreet reports. The brokerage currently has a buy rating on the stock.

Separately, Canaccord Genuity Group raised their price target on WELL Health Technologies from C$6.50 to C$7.75 and gave the stock a “buy” rating in a report on Thursday, July 9th. Five equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of C$7.40.

WELL Health Technologies Stock Performance

Shares of WELL opened at C$4.27 on Monday. The company has a current ratio of 0.80, a quick ratio of 1.02 and a debt-to-equity ratio of 100.05. The firm has a market cap of C$1.09 billion, a PE ratio of 213.50, a P/E/G ratio of -1.93 and a beta of 0.71. WELL Health Technologies has a 12 month low of C$3.58 and a 12 month high of C$6.08. The stock has a fifty day moving average price of C$4.28 and a 200-day moving average price of C$4.21.

WELL Health Technologies (TSE:WELL) last announced its earnings results on Thursday, August 6th. The company reported C$0.04 earnings per share for the quarter. WELL Health Technologies had a return on equity of 0.44% and a net margin of 0.25%.The firm had revenue of C$400.43 million for the quarter. Equities research analysts predict that WELL Health Technologies will post 0.3000698 earnings per share for the current fiscal year.

About WELL Health Technologies

WELL Health Technologies Corp. (TSX: WELL) is Canada’s largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates more than 250 clinics in Canada, supporting more than 5 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services.